KMG Chemicals Reports Fourth Quarter and Full Year 2012 Financial Results

KMG Chemicals Reports Fourth Quarter and Full Year 2012 Financial Results

HOUSTON--(BUSINESS WIRE)-- KMG Chemicals, Inc. (NYS: KMG) , a global provider of specialty chemicals in select markets, today announced financial results for its fourth fiscal quarter and fiscal year ended July 31, 2012.

2012 Fourth Fiscal Quarter Highlights

  • Net sales were $67.6 million, down 4.7% from the comparable quarter in the year-ago period.
  • Gross profit margins increased to 30.5%, from 23.9% in the fourth fiscal quarter of 2011.
  • Operating income increased 167% to $6.7 million vs. $2.5 million in the same period a year ago.
  • Diluted earnings per share from continuing operations more than tripled to $0.34 vs. $0.09 per share reported in last year's fourth fiscal quarter.
  • Electronic Chemicals segment operating margins (after corporate allocations) improved to 10.0% vs. 0.7% in the fourth fiscal quarter of 2011.

2012 Fiscal Year Highlights

  • Net sales were $273 million, a 6.6% increase from $256 million in fiscal 2011.
  • Operating income rose 49% to $25.4 million vs. $17.0 million in fiscal 2011.
  • Diluted earnings per share from continuing operations were $1.24, a 51% increase from last year's $0.82 in diluted earnings per share from continuing operations.
  • Electronic Chemicals segment sales grew to a record $159 million, up 5.3% from fiscal 2011.
  • Electronic Chemicals segment operating margins (after corporate allocations) more than doubled to 8.4%, from 4.1% in fiscal 2011.
  • Wood Treating Chemicals segment sales were $113 million, up 8.6% from $104 million in fiscal 2011.
  • Net cash provided by operating activities was $25.2 million, compared to $12.7 million in fiscal 2011.

Neal Butler, President and CEO of KMG, commented, "We are pleased with our fiscal 2012 results, which included a 51% year/year increase in diluted earnings per share from continuing operations, particularly in light of continued economic weakness in Europe and sluggish economic growth in the U.S. We have made significant progress in integrating and optimizing acquired assets in our Electronic Chemicals business, resulting in segment operating margins more than doubling on a year-over-year basis. While our Wood Treating Chemicals business remains an important contributor to our overall performance, this business has underperformed our expectations recently. However, we are taking steps to improve performance as fiscal 2013 progresses."

Electronic Chemicals

Electronic Chemical sales increased 9% to $43.1 million from the third fiscal quarter of 2012 and 7% from the fourth quarter of fiscal 2011. Overall demand for KMG's high purity electronic chemicals remained firm in the fourth fiscal quarter, aided in part by customer fabrication facility expansions.

Segment operating margins improved strongly on a year/year basis, reaching 10.0% in the fourth fiscal quarter of 2012 compared to 0.7% in the fourth quarter of fiscal 2011. The improvement in operating profitability is related to the realization of previous pricing adjustments that were implemented in response to prior raw material cost increases and additional operating efficiencies gained from our integration of the assets of General Chemical.

Wood Treating Chemicals

Wood Treating Chemicals sales declined to $24.3 million in the fourth fiscal quarter, from $30.8 million in the same period a year ago, reflecting lower shipment volumes. The decline in volumes is primarily attributable to increased competitive pressures from alternative processes and materials in the rail tie treating market.

Wood Treating Chemicals segment operating margins (after corporate allocations) increased to 13.2% in the fourth fiscal quarter, from 11.0% in the fourth fiscal quarter of 2011. Margins were helped by our pentachlorophenol (penta) product line, which continues to perform well, benefiting from strong market demand for mid-level transmission poles.

Balance Sheet and Cash Flow Overview

John V. Sobchak, CFO of KMG, said, "We ended fiscal 2012 with long-term debt of $24 million, down from $49.3 million, including current maturities, at the close of fiscal 2011. Our long-term debt-to-shareholders' equity ratio was 22.5% as of July 31, 2012 vs. 42.8% at the end of fiscal 2011. Cash flow remained strong, as KMG generated net cash from operating activities of $25.2 million for the fiscal 2012 year."

Sale of Animal Health Business

As previously announced, KMG sold its Animal Health business to Bayer Healthcare LLC in the third quarter of fiscal 2012. KMG has classified this divestiture as a discontinued operation for all periods presented. Prior-year information has been reclassified to conform to the current period presentation.


Mr. Butler commented, "Despite continued economic weakness in Europe, and to a lesser extent, the U.S., we anticipate that our fiscal first quarter diluted earnings per share will be comparable to those reported in the prior fiscal year. We have been encouraged by demand trends within our Electronic Chemicals business and anticipate our results within this segment will remain stable in the first fiscal quarter, aided by customer fab expansion activities. As always, we remain active in pursuing accretive acquisitions and have identified promising opportunities in both the Electronic Chemicals and Wood Treating Chemicals segments. Our strong cash flow and healthy balance sheet give us ample flexibility to finance future investments."

Conference Call

Date: Friday, October 12, 2012
Time: 10:00 am EDT
Dial-in: 888-396-2356 or 617-847-8709
Participant passcode: 22829677

The conference call will also be webcast live via the "Investor Relations" section of the Company's website at To listen to the live call, please go to the website at least 15 minutes early to register, download and install any necessary audio software.

If you are unable to listen live, the conference call will be archived on the KMG website. A telephone replay of the call will also be available for one week, starting at 12:00 p.m. ET on October 12, 2012. To access the call, dial 888-286-8010 or 617-801-6888 using participant passcode 24054264.

About KMG

KMG Chemicals, Inc., through its subsidiaries, produces and distributes specialty chemicals to carefully focused markets. The Company grows by acquiring and optimizing stable chemical product lines and businesses with established production processes. Its current operations are focused on the electronic and industrial wood treatment chemical markets. For more information, visit the Company's web site at

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements as to the future performance of the company. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development acceptance, the impact of competitive services and pricing and general economic risks and uncertainties.




(In thousands, except per share amounts)

Three Months Ended
July 31,
Year Ended
July 31,
2012 20112012 2011
Net sales$67,607$70,936$272,700$255,596
Cost of sales





Gross profit





Distribution expenses7,4808,07826,77028,821
Selling, general and administrative expenses





Operating income





Other income/(expense)
Interest income11
Interest expense(490)(571)(2,100)(2,336)
Other, net





Total other expense, net





Income from continuing operations before income taxes





Provision for income taxes





Income from continuing operations





Discontinued operations
Income/(loss) from discontinued operations, before income taxes(277)180(711)514
Income tax benefit/(expense)





Income/(loss) from discontinued operations





Net income$3,863$1,182$13,825$9,729
Earnings per share
Income from continuing operations$0.35$0.09$1.26$0.83
Income/(loss) from discontinued operations





Net income$0.34$0.10$1.22$0.86
Income from continuing operations$0.34$0.09$1.24$0.82
Income/(loss) from discontinued operations





Net income$0.33$0.10$1.20$0.85
Weighted average shares outstanding



AS OF JULY 31, 2012 AND 2011

(In thousands, except for share and per share amounts)




Current assets
Cash and cash equivalents$1,633$1,826
Accounts receivable
Trade, net of allowances of $16 at July 31, 2012 and $414 at July 31, 201128,93336,410
Inventories, net40,66141,770
Current deferred tax assets1,417726
Prepaid expenses and other 2,057 2,126
Total current assets75,66186,006
Property, plant and equipment, net68,02671,826
Deferred tax assets1,1291,176
Intangible assets, net14,98019,493
Restricted cash1,000
Other assets, net 3,116 3,099
Total assets$167,690$185,378
Liabilities & stockholders' equity
Current liabilities
Accounts payable$21,855$24,899
Accrued liabilities4,5953,921
Book overdraft2,852
Current deferred tax liabilities7
Current maturities of long-term debt8,000
Employee incentive accrual 2,227 1,103
Total current liabilities28,67740,782
Long-term debt, net of current maturities24,00041,279
Deferred tax liabilities7,0465,381
Other long-term liabilities 1,200 1,406
Total liabilities60,92388,848
Commitments and contingencies
Stockholders' equity
Preferred stock, $.01 par value, 10,000,000 shares authorized, none issued
Common stock, $.01 par value, 40,000,000 shares authorized, 11,405,808 shares issued and outstanding at July 31, 2012 and 11,318,941 shares issued and outstanding at July 31, 2011114113
Additional paid-in capital26,02225,256
Accumulated other comprehensive loss(4,339)(1,233)
Retained earnings 84,970 72,394
Total stockholders' equity 106,767 96,530
Total liabilities and stockholders' equity$167,690$185,378



FOR THE YEARS ENDED JULY 31, 2012 and 2011

(In thousands)

Cash flows from operating activities
Net income$13,825$9,729
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization7,0187,354
Amortization of loan costs included in interest expense124109
Stock-based compensation expense714542
Bad debt expense154
Inventory valuation adjustment371(94)
Gain on sale of animal health business(90)?
Read Full Story
Scroll to continue with content AD
More to Explore